BeStock  
Stocks › Biotechnology › FTRE

Fortrea Holdings FTRE

US equityMarket cap rank #2754Biotechnology
$18.55 −$1.60 (-7.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.55 0.00%
Open$19.89
Prev close$20.15
Day range$18.30 – $20.52
Volume1.54M
Market cap$1.79B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$691.50M-1.4% YoY
Operating profit$15.70M+524.3% YoY
Net profit$600,000.00+103.8% YoY
Diluted EPS$0.01+105.9% YoY
Free cash flow$52.50M-34.0% YoY
Operating cash flow$60.80M

Revenue, last 8 quarters

$697.0MDec '24$651.3MMar '25$710.3MJun '25$701.3MSep '25$660.5MDec '25$636.5MMar '26$678.2MJun '26$691.5MSep '26

Net profit, last 8 quarters

$-61.2MDec '24$-562.9MMar '25$-374.9MJun '25$-15.9MSep '25$-32.5MDec '25$-23.6MMar '26$-13.2MJun '26$600.0KSep '26

Diluted EPS by quarter

-0.68Dec '24-6.25Mar '25-4.14Jun '25-0.17Sep '25-0.35Dec '25-0.25Mar '26-0.14Jun '260.01Sep '26

Free cash flow by quarter

$20.3MDec '24$-127.1MMar '25$14.3MJun '25$79.5MSep '25$121.6MDec '25$-25.0MMar '26$19.9MJun '26$52.5MSep '26

Annual revenue

$2.6BFY20$3.1BFY21$2.8BFY22$2.8BFY23$2.7BFY24$2.7BFY25

Profitability & balance sheet

Gross margin20.0%
Operating margin1.7%
Net margin-2.6%
Return on equity-12.3%
Return on assets-2.5%
Return on invested capital-1.1%
Current ratio0.97
Liabilities / assets80.6%
Cash & investments$220.60M
Total debt$1.11B
Net cash (debt)-$888.50M
Free cash flow / sales6.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $691.50M $678.20M $636.50M $2.72B $660.50M
Total Operating Revenue $691.50M $678.20M $636.50M $2.72B $660.50M
Cost of Revenue $552.00M $539.00M $512.90M $2.22B $529.40M
Gross Profit $139.50M $139.20M $123.60M $503.80M $131.10M
Operating Expense $123.80M $121.70M $120.30M $534.40M $122.30M
Selling and Admin Expenses $103.80M $102.10M $100.50M $456.40M $103.00M
Depreciation & Amortization & Depletion $20.00M $19.60M $19.80M $78.00M $19.30M
-Depreciation & Amortization $20.00M $19.60M $19.80M $78.00M $19.30M
Operating Profit $15.70M $17.50M $3.30M -$30.60M $8.80M
Net Non-Operating Interest Income (Expense) -$20.20M -$19.30M -$19.10M -$91.40M -$23.20M
Non-Operating Interest Expense $20.20M $19.30M $19.10M $91.40M $23.20M
Other Income (Expense) $900,000.00 $600,000.00 $3.50M -$861.00M -$21.20M
Gain on Sale of Security $1.30M $3.50M $9.70M -$26.90M $1.20M
Special Income (Charges) -$700,000.00 -$2.70M -$6.70M -$842.00M -$22.40M
-Less:Restructuring and Mergern & Acquisition $700,000.00 $2.70M $6.70M $40.90M $19.20M
-Less:Impairment of Capital Assets $0.00 $0.00 $0.00 $797.90M $0.00
Other Non-Operating Income (Expenses) $300,000.00 -$200,000.00 $500,000.00 $7.90M $0.00
Pretax Profit -$3.60M -$1.20M -$12.30M -$983.00M -$35.60M
Tax -$4.20M $12.00M $11.30M $3.20M -$3.10M
Net Profit $600,000.00 -$13.20M -$23.60M -$986.20M -$32.50M
Profit from Continuing Operations $600,000.00 -$13.20M -$23.60M -$986.20M -$32.50M
Net Income to Parent Company $600,000.00 -$13.20M -$23.60M -$986.20M -$32.50M
Net Income to Common Stockholders $600,000.00 -$13.20M -$23.60M -$986.20M -$32.50M
Basic EPS $0.01 -$0.14 -$0.25 -$10.81 -$0.35
Diluted EPS $0.01 -$0.14 -$0.25 -$10.81 -$0.35
-Less:Write Off – – – $3.20M –
Net Income from Discontinuous Operations – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.74B $2.71B $2.68B $2.72B $2.72B
Total Current Assets $952.70M $923.60M $881.50M $897.20M $897.20M
Cash and Cash Equivalents & Short-Term Investments $220.60M $168.60M $147.50M $174.60M $174.60M
-Cash and Cash Equivalents $220.60M $168.60M $147.50M $174.60M $174.60M
Receivables $641.10M $654.40M $619.60M $620.00M $620.00M
-Accounts Receivable $171.60M $189.00M $129.00M $113.60M $113.60M
-Other Receivables $506.10M $503.40M $527.50M $517.30M $517.30M
-Receivables Adjustments Allowances -$36.60M -$38.00M -$36.90M -$41.20M -$41.20M
Other Current Assets $91.00M $100.60M $114.40M $37.60M $37.60M
Total Non-Current Assets $1.79B $1.79B $1.80B $1.82B $1.82B
Net PPE $158.60M $156.20M $157.10M $149.50M $149.50M
Goodwill and Other Intangible Assets $1.52B $1.54B $1.55B $1.58B $1.58B
-Goodwill $949.90M $950.30M $950.80M $960.00M $960.00M
-Other Intangible Assets $572.00M $586.80M $601.70M $622.00M $622.00M
Non-Current Deferred Assets $6.20M $6.20M $6.20M $6.20M $6.20M
Other Non-Current Assets $98.80M $91.80M $86.10M $80.80M $80.80M
Total Liabilities $2.21B $2.19B $2.16B $2.15B $2.15B
Total Current Liabilities $983.30M $963.70M $929.10M $913.30M $913.30M
Payables $53.00M $54.20M $70.80M $88.70M $88.70M
-Accounts Payable $53.00M $54.20M $70.80M $29.70M $29.70M
Current Accrued Expenses $372.10M $380.80M $357.30M $167.90M $167.90M
Short-Term Debt and Capital Lease Obligation $32.70M $26.00M $19.70M $14.00M $14.00M
-Current Debt $23.40M $17.10M $10.90M $4.80M $4.80M
-Current Capital Lease Obligation $9.30M $8.90M $8.80M $9.20M $9.20M
Current Deferred Liabilities $525.50M $502.70M $481.30M $473.80M $473.80M
Total Non-Current Liabilities $1.22B $1.23B $1.23B $1.24B $1.24B
Long Term Debt and Capital Lease Obligation $1.09B $1.09B $1.10B $1.10B $1.10B
-Long Term Debt $1.03B $1.04B $1.04B $1.05B $1.05B
-Long Term Capital Lease Obligation $53.80M $54.30M $55.70M $54.00M $54.00M
Non-Current Deferred Liabilities $97.10M $97.00M $92.30M $97.60M $97.60M
Other Non-Current Liabilities $39.80M $38.50M $37.80M $39.30M $39.30M
Total Equity $532.30M $524.20M $525.90M $563.50M $563.50M
Stockholders' Equity $532.30M $524.20M $525.90M $563.50M $563.50M
Capital Stock $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-Common Stock $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
Additional Paid-In Capital $2.15B $2.14B $2.13B $2.12B $2.12B
Retained Earnings -$1.42B -$1.42B -$1.41B -$1.38B -$1.38B
Gains/Losses Not Affecting Retained Earnings -$201.00M -$196.50M -$195.40M -$170.00M -$170.00M
-Taxes Receivable – – – $30.30M $30.30M
Prepaid Assets – – – $65.00M $65.00M
-Gross PPE – – – $332.80M $332.80M
-Accumulated Depreciation – – – -$183.30M -$183.30M
-Total Tax Payable – – – $59.00M $59.00M
Other Current Liabilities – – – $28.20M $28.20M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $60.80M $28.90M -$17.00M $113.50M $129.10M
Net cash flow from continuing operations $60.80M $28.90M -$17.00M $113.50M $129.10M
Net Income from Continuing Operations $600,000.00 -$13.20M -$23.60M -$986.20M -$32.50M
Gain/Loss from Continuing Operations -$4.50M -$500,000.00 -$8.20M $36.40M -$2.40M
Depreciation & Depletion & Amortization $20.00M $19.60M $19.80M $78.00M $19.30M
Deferred Tax $100,000.00 $4.90M -$4.00M -$32.00M -$7.60M
Other Non-Cash Items $2.40M $4.20M $2.40M $16.00M $5.20M
Change in Working Capital $30.20M $300,000.00 -$17.80M $114.70M $132.80M
-Change in Receivables $14.70M -$36.30M -$33.70M $70.90M $81.50M
-Change in Prepaid Assets $2.80M $6.10M $11.40M $32.40M -$11.40M
-Change in Payables and Accrued Expense -$9.60M $8.40M -$2.10M -$103.40M $2.50M
-Change In Other Working Capital $22.30M $22.10M $6.60M $114.80M $60.20M
Net cash flow from investing -$8.30M -$7.00M -$8.00M $14.40M -$7.50M
Net Cash Flow from Continuing Investing Activities -$8.30M -$7.00M -$8.00M $14.40M -$7.50M
Capital Expenditure -$8.30M -$9.00M -$8.00M -$25.20M -$7.50M
Net Business Purchase and Sale $0.00 $0.00 $0.00 $39.60M $0.00
Net Other Investing Changes $0.00 – – – –
Financing Cash Flow $0.00 $0.00 $0.00 -$76.30M -$75.70M
Net Cash Flow from Continuing Financing Activities $0.00 $0.00 $0.00 -$76.30M -$75.70M
Net Issuance Payments Of Debt $0.00 $0.00 $0.00 -$75.70M -$75.70M
Ending Cash Balance $220.60M $168.60M $147.50M $174.60M $174.60M
Net Change in Cash $52.50M $21.90M -$25.00M $51.60M $45.90M
Beginning Cash Balance $168.60M $147.50M $174.60M $118.50M $131.30M
Effect of Exchange Rate Changes -$500,000.00 -$800,000.00 -$2.10M $4.50M -$2.60M
Free Cash Flow $52.50M $19.90M -$25.00M $88.30M $121.60M
Net Other Financing Charges – – – -$600,000.00 $0.00

Discussion

No comments yet — be the first to weigh in on FTRE.

Sign in to join the discussion.

Scroll to Top